Primary Immunodeficiency (PID)
Cross-source consensus on Primary Immunodeficiency (PID) from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Background
Highlighted claims
- PID encompasses more than 500 types of immune deficiency, with common variable immunodeficiency among the most frequent B-cell disorders. — Benefits and challenges in everyday life for patients performing subcutaneous immunoglobulin treatment at home: a qualitative interview study
- Most PID conditions are congenital, require lifelong treatment and follow-up, and have recurrent infections as a hallmark symptom. — Benefits and challenges in everyday life for patients performing subcutaneous immunoglobulin treatment at home: a qualitative interview study
- Secondary immunodeficiency may be temporary or chronic and arises from other diseases or treatments such as chemotherapy. — Benefits and challenges in everyday life for patients performing subcutaneous immunoglobulin treatment at home: a qualitative interview study
- One PID patient described feeling stigmatised by receiving hospital treatment alongside cancer patients. — Benefits and challenges in everyday life for patients performing subcutaneous immunoglobulin treatment at home: a qualitative interview study